BDNF-TrkB signaling

No Pathway Network information available for BDNF-TrkB signaling

Pathways in the BDNF-TrkB signaling SuperPath

#	Name	Source	Genes
1	BDNF-TrkB signaling	WikiPathways	ADCY1 AKT1 ARC BDNF BRAF CREB1 DLG4 EEF2K EIF4EBP1 GAB1 GAB2 GRB2 GRIN1 HOMER1 HRAS KRAS MAP2K1 MAPK1 MKNK1 MTOR NRAS NTRK2 PIK3CG PLCG1 RHEB RPS6KA1 RPS6KB1 SHC1 SOS1 TRPC3 TRPC6 TSC1 TSC2 (see all 33) (see less)
2	Synaptic signaling pathways associated with autism spectrum disorder	WikiPathways	AKT1 AKT3 ARC BDNF CACNA1C CAMK2B CAMK4 EIF4EBP1 GRIN2C GRIN3A GRIN3B GSK3B HOMER1 KRAS MAPK1 MAPK3 MTOR NF1 NRAS NTRK2 PTEN RHEB RPS6KB1 RPTOR TSC1 TSC2 UBE3A (see all 27) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	HOMER1	Homer Scaffold Protein 1	Protein Coding	2
2	TSC2	TSC Complex Subunit 2	Protein Coding	2
3	TSC1	TSC Complex Subunit 1	Protein Coding	2
4	BDNF	Brain Derived Neurotrophic Factor	Protein Coding	2
5	RPS6KB1	Ribosomal Protein S6 Kinase B1	Protein Coding	2
6	RHEB	Ras Homolog, MTORC1 Binding	Protein Coding	2
7	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	2
8	NTRK2	Neurotrophic Receptor Tyrosine Kinase 2	Protein Coding	2
9	NRAS	NRAS Proto-Oncogene, GTPase	Protein Coding	2
10	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	2
11	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	2
12	ARC	Activity Regulated Cytoskeleton Associated Protein	Protein Coding	2
13	AKT1	AKT Serine/Threonine Kinase 1	Protein Coding	2
14	EIF4EBP1	Eukaryotic Translation Initiation Factor 4E Binding Protein 1	Protein Coding	2
15	GAB2	GRB2 Associated Binding Protein 2	Protein Coding	1
16	MKNK1	MAPK Interacting Serine/Threonine Kinase 1	Protein Coding	1
17	TRPC6	Transient Receptor Potential Cation Channel Subfamily C Member 6	Protein Coding	1
18	TRPC3	Transient Receptor Potential Cation Channel Subfamily C Member 3	Protein Coding	1
19	BRAF	B-Raf Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	1
20	SOS1	SOS Ras/Rac Guanine Nucleotide Exchange Factor 1	Protein Coding	1
21	SHC1	SHC Adaptor Protein 1	Protein Coding	1
22	RPS6KA1	Ribosomal Protein S6 Kinase A1	Protein Coding	1
23	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	1
24	PLCG1	Phospholipase C Gamma 1	Protein Coding	1
25	PIK3CG	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Gamma	Protein Coding	1
26	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	1
27	GRIN1	Glutamate Ionotropic Receptor NMDA Type Subunit 1	Protein Coding	1
28	GAB1	GRB2 Associated Binding Protein 1	Protein Coding	1
29	DLG4	Discs Large MAGUK Scaffold Protein 4	Protein Coding	1
30	CREB1	CAMP Responsive Element Binding Protein 1	Protein Coding	1
31	ADCY1	Adenylate Cyclase 1	Protein Coding	1
32	EEF2K	Eukaryotic Elongation Factor 2 Kinase	Protein Coding	1
33	GRB2	Growth Factor Receptor Bound Protein 2	Protein Coding	1
34	CAMK2B	Calcium/Calmodulin Dependent Protein Kinase II Beta	Protein Coding	1
35	CAMK4	Calcium/Calmodulin Dependent Protein Kinase IV	Protein Coding	1
36	CACNA1C	Calcium Voltage-Gated Channel Subunit Alpha1 C	Protein Coding	1
37	UBE3A	Ubiquitin Protein Ligase E3A	Protein Coding	1
38	RPTOR	Regulatory Associated Protein Of MTOR Complex 1	Protein Coding	1
39	PTEN	Phosphatase And Tensin Homolog	Protein Coding	1
40	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
41	NF1	Neurofibromin 1	Protein Coding	1
42	GSK3B	Glycogen Synthase Kinase 3 Beta	Protein Coding	1
43	GRIN3A	Glutamate Ionotropic Receptor NMDA Type Subunit 3A	Protein Coding	1
44	AKT3	AKT Serine/Threonine Kinase 3	Protein Coding	1
45	GRIN3B	Glutamate Ionotropic Receptor NMDA Type Subunit 3B	Protein Coding	1
46	GRIN2C	Glutamate Ionotropic Receptor NMDA Type Subunit 2C	Protein Coding	1

Disorders associated with BDNF-TrkB signaling SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Rasopathy	Enrichment	BRAF, HRAS, KRAS, MAP2K1, NRAS, SOS1	10.69
2	Noonan syndrome 1	Enrichment	BRAF, HRAS, KRAS, MAP2K1, NRAS, SOS1	10.56
3	Noonan syndrome and noonan-related syndrome	Enrichment	BRAF, HRAS, KRAS, MAP2K1, NRAS, SOS1	10.54
4	Focal cortical dysplasia, type ii	Enrichment	MTOR, RHEB, TSC1, TSC2	10.33
5	Isolated focal cortical dysplasia type ii	Enrichment	MTOR, RHEB, TSC1, TSC2	10.33
6	Lung non-small cell carcinoma	Enrichment	BRAF, HRAS, KRAS, MAP2K1, NRAS	10.29
7	Hemimegalencephaly	Enrichment	AKT3, MTOR, PTEN, RHEB	10.07
8	Langerhans cell histiocytosis	Enrichment	BRAF, MAP2K1, NRAS	7.88
9	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS, KRAS, NRAS	7.28
10	Cardiofaciocutaneous syndrome 1	Enrichment	BRAF, KRAS, MAP2K1	7.28
11	Cardiofaciocutaneous syndrome	Enrichment	BRAF, KRAS, MAP2K1	7.28
12	Bladder cancer	Enrichment	KRAS, NF1, PTEN, TSC1	6.54
13	Nevus, epidermal	Enrichment	HRAS, KRAS, NRAS	6.34
14	Thyroid cancer, nonmedullary, 2	Enrichment	BRAF, HRAS, NRAS	6.34
15	Noonan syndrome 3	Enrichment	HRAS, KRAS, SOS1	6.34
16	Pilomyxoid astrocytoma	Enrichment	BRAF, KRAS, NTRK2	6.34
17	Follicular thyroid carcinoma	Enrichment	BRAF, HRAS, NRAS	6.34
18	Differentiated thyroid carcinoma	Enrichment	BRAF, HRAS, KRAS, NRAS	6.18
19	Melanocytic nevus syndrome, congenital	Enrichment	BRAF, HRAS, NRAS	6.14
20	Juvenile myelomonocytic leukemia	Enrichment	KRAS, NF1, NRAS	5.82
21	Lymphangioleiomyomatosis	Enrichment	TSC1, TSC2	5.42
22	Ras-associated autoimmune leukoproliferative disorder	Enrichment	KRAS, NRAS	5.42
23	Pulmonic stenosis	Enrichment	BRAF, SOS1	5.24
24	Tuberous sclerosis 1	Enrichment	TSC1, TSC2	4.94
25	Hamartoma	Enrichment	TSC1, TSC2	4.94
26	Large congenital melanocytic nevus	Enrichment	HRAS, NRAS	4.76
27	Chronic myelogenous leukemia, bcr-abl1 positive	Enrichment	KRAS, NRAS	4.64
28	Tuberous sclerosis	Enrichment	TSC1, TSC2	4.64
29	Pilocytic astrocytoma	Enrichment	KRAS, NF1	4.64
30	Ovarian cancer	Enrichment	AKT1, KRAS, PTEN, TSC2	4.35
31	Breast adenocarcinoma	Enrichment	AKT1, KRAS	4.24
32	Leukemia, chronic myeloid	Enrichment	KRAS, NRAS	4.10
33	Gastric cancer	Enrichment	KRAS, NF1, PTEN	4.08
34	Hereditary breast carcinoma	Enrichment	AKT1, KRAS, PTEN	4.05
35	Capillary malformation-arteriovenous malformation 1	Enrichment	KRAS, MAP2K1	3.92
36	Gallbladder cancer	Enrichment	BRAF, KRAS	3.92
37	Inherited cancer-predisposing syndrome	Enrichment	NF1, PTEN, TSC1, TSC2	3.90
38	Adult hepatocellular carcinoma	Enrichment	TSC1, TSC2	3.87
39	Cowden syndrome	Enrichment	AKT1, PTEN	3.87
40	West syndrome	Enrichment	GRIN1, NTRK2, TSC2	3.79
41	Hereditary breast ovarian cancer syndrome	Enrichment	KRAS, NF1, PTEN	3.76
42	Arteriovenous malformation	Enrichment	HRAS, MAP2K1	3.69
43	Meningioma	Enrichment	AKT1, PTEN	3.60
44	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS, MAP2K1	3.59
45	Lip and oral cavity carcinoma	Enrichment	BRAF, HRAS	3.43
46	Breast cancer	Enrichment	AKT1, KRAS, PTEN	3.36
47	Rhabdomyosarcoma	Enrichment	NF1, PTEN	3.35
48	Lung cancer susceptibility 3	Enrichment	BRAF, KRAS	3.29
49	Arteriovenous malformations of the brain	Enrichment	BRAF, KRAS	3.02
50	Congenital nervous system abnormality	Enrichment	CAMK2B, PTEN, TSC2	2.93
51	Nervous system disease	Enrichment	CAMK2B, PTEN, TSC2	2.93
52	Colorectal cancer	Enrichment	AKT1, BRAF, NRAS	2.92
53	Autism spectrum disorder	Enrichment	NF1, PTEN, TSC2	2.89
54	Proteus syndrome	Enrichment	AKT1	2.70
55	Oculoectodermal syndrome	Enrichment	KRAS	2.70
56	Vacterl association with hydrocephalus	Enrichment	PTEN	2.70
57	Melanosis, neurocutaneous	Enrichment	NRAS	2.70
58	Noonan syndrome 6	Enrichment	NRAS	2.70
59	Noonan syndrome 13	Enrichment	MAPK1	2.70
60	Developmental and epileptic encephalopathy 58	Enrichment	NTRK2	2.70
61	Intellectual developmental disorder, autosomal dominant 54	Enrichment	CAMK2B	2.70
62	Papillary tumor of the pineal region	Enrichment	PTEN	2.70
63	Cardiofaciocutaneous syndrome 2	Enrichment	KRAS	2.70
64	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2	Enrichment	AKT3	2.70
65	Brugada syndrome 3	Enrichment	CACNA1C	2.70
66	Cowden syndrome 6	Enrichment	AKT1	2.70
67	Obesity, hyperphagia, and developmental delay	Enrichment	NTRK2	2.70
68	Glioma susceptibility 2	Enrichment	PTEN	2.70
69	Plexiform neurofibroma	Enrichment	NF1	2.70
70	Neurofibroma	Enrichment	NF1	2.70
71	Capillary hemangioma	Enrichment	AKT3	2.70
72	Neurofibromatosis	Enrichment	NF1	2.70
73	Chromosome 17q11.2 deletion syndrome	Enrichment	NF1	2.70
74	Congenital pulmonary airway malformation	Enrichment	KRAS	2.70
75	Optic nerve glioma	Enrichment	NF1	2.70
76	Atypical timothy syndrome	Enrichment	CACNA1C	2.70
77	15q11q13 microduplication syndrome	Enrichment	UBE3A	2.70
78	Timothy syndrome type 2	Enrichment	CACNA1C	2.70
79	Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome	Enrichment	PTEN	2.70
80	Timothy syndrome type 1	Enrichment	CACNA1C	2.70
81	Neurocutaneous melanocytosis	Enrichment	NRAS	2.70
82	Cacna1c-related disorders	Enrichment	CACNA1C	2.70
83	Deafness, autosomal recessive 26	Enrichment	GAB1	2.61
84	Noonan syndrome 4	Enrichment	SOS1	2.61
85	Melorheostosis, isolated	Enrichment	MAP2K1	2.61
86	Noonan syndrome 7	Enrichment	BRAF	2.61
87	Leopard syndrome 3	Enrichment	BRAF	2.61
88	Focal segmental glomerulosclerosis 2	Enrichment	TRPC6	2.61
89	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.61
90	Deafness, autosomal recessive 44	Enrichment	ADCY1	2.61
91	Spinocerebellar ataxia 41	Enrichment	TRPC3	2.61
92	Immune dysregulation, autoimmunity, and autoinflammation	Enrichment	PLCG1	2.61
93	Lymphangioma	Enrichment	BRAF	2.61
94	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive	Enrichment	GRIN1	2.61
95	Phace association	Enrichment	BRAF	2.61
96	Melorheostosis	Enrichment	MAP2K1	2.61
97	Immunodeficiency 97 with autoinflammation	Enrichment	PIK3CG	2.61
98	Developmental and epileptic encephalopathy 101	Enrichment	GRIN1	2.61
99	Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant	Enrichment	GRIN1	2.61
100	Syringocystadenoma papilliferum	Enrichment	BRAF	2.61
101	Ganglioglioma	Enrichment	BRAF	2.61
102	Intellectual disability, autosomal dominant 8	Enrichment	GRIN1	2.61
103	Nongerminomatous germ cell tumor	Enrichment	BRAF	2.61
104	Phace syndrome	Enrichment	BRAF	2.61
105	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.61
106	Classic hairy cell leukemia	Enrichment	BRAF	2.61
107	Non-immune hydrops fetalis	Enrichment	HRAS, KRAS	2.59
108	Lung cancer	Enrichment	BRAF, KRAS	2.57
109	Leukemia, acute myeloid	Enrichment	KRAS, NRAS	2.55
110	Cafe-au-lait spots, multiple	Enrichment	NF1	2.40
111	Timothy syndrome	Enrichment	CACNA1C	2.40
112	Encephalocraniocutaneous lipomatosis	Enrichment	KRAS	2.40
113	Long qt syndrome 8	Enrichment	CACNA1C	2.40
114	Cebalid syndrome	Enrichment	MTOR	2.40
115	Chromosome 17q11.2 duplication syndrome, 1.4-mb	Enrichment	NF1	2.40
116	Senior-loken syndrome 7	Enrichment	AKT3	2.40
117	Bardet-biedl syndrome 9	Enrichment	NF1	2.40
118	Bardet-biedl syndrome 16	Enrichment	AKT3	2.40
119	Smith-kingsmore syndrome	Enrichment	MTOR	2.40
120	Vacterl with hydrocephalus	Enrichment	PTEN	2.40
121	Angelman syndrome due to maternal 15q11q13 deletion	Enrichment	UBE3A	2.40
122	Juvenile polyposis of infancy	Enrichment	PTEN	2.40
123	Pleomorphic rhabdomyosarcoma	Enrichment	NF1	2.40
124	Fibromatosis, gingival, 1	Enrichment	SOS1	2.31
125	Costello syndrome	Enrichment	HRAS	2.31
126	Histiocytoma, angiomatoid fibrous	Enrichment	CREB1	2.31
127	Bilateral generalized polymicrogyria	Enrichment	GRIN1	2.31
128	Vulto-van silfhout-de vries syndrome	Enrichment	DLG4	2.31
129	Wooly hair nevus	Enrichment	HRAS	2.31
130	Myeloma, multiple	Enrichment	KRAS, NF1	2.26
131	Watson syndrome	Enrichment	NF1	2.22
132	Polycystic kidney disease, infantile severe, with tuberous sclerosis	Enrichment	TSC2	2.22
133	Neurofibromatosis, familial spinal	Enrichment	NF1	2.22
134	Tuberous sclerosis 2	Enrichment	TSC2	2.22
135	Chromosome 17q11.2 deletion syndrome, 1.4-mb	Enrichment	NF1	2.22
136	Auditory neuropathy and optic atrophy	Enrichment	GRIN2C	2.22
137	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	Enrichment	CACNA1C	2.22
138	Xanthinuria, type ii	Enrichment	TSC2	2.22
139	Brain cancer	Enrichment	NF1	2.22
140	Laryngeal squamous cell carcinoma	Enrichment	PTEN	2.22
141	Angelman syndrome due to imprinting defect in 15q11-q13	Enrichment	UBE3A	2.22
142	Ataxia-telangiectasia	Enrichment	BRAF	2.14
143	Heart defects, congenital, and other congenital anomalies	Enrichment	DLG4	2.14
144	Nuchal bleb, familial	Enrichment	SOS1	2.14
145	Tethered spinal cord syndrome	Enrichment	BRAF	2.14
146	Intellectual developmental disorder, autosomal dominant 62	Enrichment	DLG4	2.14
147	Neurodevelopmental disorder with hypotonia and impaired expressive language and with or without seizures	Enrichment	DLG4	2.14
148	Dlg4-related synaptopathy	Enrichment	DLG4	2.14
149	Spermatocytoma	Enrichment	HRAS	2.14
150	Melanoma of soft tissue	Enrichment	CREB1	2.14
151	Diffuse gastric and lobular breast cancer syndrome	Enrichment	KRAS	2.10
152	Neurofibromatosis-noonan syndrome	Enrichment	NF1	2.10
153	Megalencephaly-capillary malformation-polymicrogyria syndrome	Enrichment	AKT3	2.10
154	Ventricular fibrillation, paroxysmal familial, 1	Enrichment	CACNA1C	2.10
155	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	2.10
156	Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1	Enrichment	AKT3	2.10
157	Lung sarcomatoid carcinoma	Enrichment	KRAS	2.10
158	Embryonal rhabdomyosarcoma	Enrichment	NF1	2.10
159	Glioma	Enrichment	PTEN	2.10
160	Middle aortic syndrome	Enrichment	NF1	2.10
161	Acyl-coa dehydrogenase, very long-chain, deficiency of	Enrichment	DLG4	2.01
162	Thyroid cancer, nonmedullary, 1	Enrichment	BRAF	2.01
163	Craniopharyngioma	Enrichment	BRAF	2.01
164	Noonan syndrome with multiple lentigines	Enrichment	BRAF	2.01
165	Newborn respiratory distress syndrome	Enrichment	BRAF	2.01
166	Epidermolytic nevus	Enrichment	HRAS	2.01
167	Gingival fibromatosis	Enrichment	SOS1	2.01
168	Rhabdomyosarcoma 2	Enrichment	NF1	2.00
169	Macrocephaly/autism syndrome	Enrichment	PTEN	2.00
170	Heart conduction disease	Enrichment	CACNA1C	2.00
171	Hemangioma	Enrichment	PTEN	2.00
172	Acute megakaryocytic leukemia	Enrichment	PTEN	2.00
173	Angelman syndrome	Enrichment	UBE3A	1.92
174	Cowden syndrome 1	Enrichment	PTEN	1.92
175	Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome	Enrichment	BDNF	1.92
176	Keratoconus	Enrichment	TSC1	1.92
177	Lung squamous cell carcinoma	Enrichment	KRAS	1.92
178	Polycystic kidney disease 1 with or without polycystic liver disease	Enrichment	TSC2	1.86
179	Squamous cell carcinoma, head and neck	Enrichment	PTEN	1.86
180	Renal cell carcinoma, papillary, 1	Enrichment	MTOR	1.86
181	Polycystic kidney disease 1	Enrichment	TSC2	1.86
182	Megacolon	Enrichment	AKT3	1.86
183	Overgrowth syndrome	Enrichment	MTOR	1.86
184	Wilms tumor 5	Enrichment	BRAF	1.84
185	Ewing sarcoma	Enrichment	NF1	1.80
186	Neurofibromatosis, type i	Enrichment	NF1	1.75
187	Leukemia, acute lymphoblastic 3	Enrichment	NF1	1.75
188	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	CACNA1C	1.75
189	Congenital central hypoventilation syndrome	Enrichment	BDNF	1.75
190	Lymphoma, non-hodgkin, familial	Enrichment	BRAF	1.71
191	Polymicrogyria	Enrichment	AKT3	1.70
192	Melanoma	Enrichment	PTEN	1.70
193	Meningioma, familial	Enrichment	PTEN	1.66
194	Uterine corpus cancer	Enrichment	PTEN	1.66
195	Specific learning disability	Enrichment	MAPK1	1.66
196	Cardiomyopathy, familial hypertrophic, 4	Enrichment	BRAF	1.66
197	Primary hyperaldosteronism	Enrichment	BRAF	1.66
198	Ventricular septal defect	Enrichment	BRAF	1.66
199	Cardiac conduction defect	Enrichment	CACNA1C	1.63
200	Microcephaly	Enrichment	CAMK2B, MAPK1	1.61
201	Protein-deficiency anemia	Enrichment	NRAS	1.59
202	Pheochromocytoma	Enrichment	NF1	1.56
203	Renal cell carcinoma, nonpapillary	Enrichment	MTOR	1.53
204	Lynch syndrome	Enrichment	KRAS	1.53
205	Autosomal dominant polycystic kidney disease	Enrichment	TSC2	1.53
206	Kidney disease	Enrichment	TSC1	1.53
207	Rare genetic intellectual disability	Enrichment	MTOR	1.53
208	Aortic valve disease 1	Enrichment	SOS1	1.51
209	46,xy partial gonadal dysgenesis	Enrichment	SOS1	1.47
210	Heart, malformation of	Enrichment	MAPK1	1.45
211	Wilms tumor 1	Enrichment	BRAF	1.44
212	Diffuse large b-cell lymphoma	Enrichment	PTEN	1.43
213	Melanoma, cutaneous malignant 1	Enrichment	BRAF	1.39
214	Dandy-walker syndrome	Enrichment	BRAF	1.39
215	Endometrial cancer	Enrichment	PTEN	1.39
216	Hereditary paraganglioma-pheochromocytoma syndromes	Enrichment	NF1	1.39
217	Skin disease	Enrichment	NF1	1.37
218	Early infantile developmental and epileptic encephalopathy	Enrichment	GRIN1	1.37
219	Cardiomyopathy, familial hypertrophic, 1	Enrichment	CACNA1C	1.33
220	Focal segmental glomerulosclerosis	Enrichment	TRPC6	1.32
221	Pancreatic cancer	Enrichment	KRAS	1.31
222	Brugada syndrome	Enrichment	CACNA1C	1.30
223	Prostate cancer	Enrichment	PTEN	1.25
224	Long qt syndrome 1	Enrichment	CACNA1C	1.24
225	Developmental and epileptic encephalopathy 1	Enrichment	GRIN1	1.23
226	Long qt syndrome	Enrichment	CACNA1C	1.22
227	Hydrops fetalis, nonimmune	Enrichment	HRAS	1.21
228	Dystonia	Enrichment	CAMK2B	1.17
229	Cerebral palsy	Enrichment	CACNA1C	1.13
230	Genetic steroid-resistant nephrotic syndrome	Enrichment	TRPC6	1.10
231	Body mass index quantitative trait locus 11	Enrichment	BDNF	1.02
232	Autosomal dominant non-syndromic intellectual disability	Enrichment	CAMK2B	1.02
233	Benign epilepsy with centrotemporal spikes	Enrichment	GRIN1	1.02
234	Centralopathic epilepsy	Enrichment	GRIN1	1.00
235	Nephrotic syndrome	Enrichment	TRPC6	1.00
236	Undetermined early-onset epileptic encephalopathy	Enrichment	NTRK2	0.98
237	Autosomal recessive non-syndromic intellectual disability	Enrichment	GRIN1	0.88
238	Dilated cardiomyopathy	Enrichment	BRAF	0.75
239	Rare autosomal recessive non-syndromic sensorineural deafness type dfnb	Enrichment	ADCY1	0.71
240	Complex neurodevelopmental disorder	Enrichment	CACNA1C	0.66

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

BDNF-TrkB signaling

Pathway Network for BDNF-TrkB signaling

Member Pathways for BDNF-TrkB signaling

Pathways in the BDNF-TrkB signaling SuperPath

Associated Genes for BDNF-TrkB signaling

Associated Disorders for BDNF-TrkB signaling

Disorders associated with BDNF-TrkB signaling SuperPath

STRING Interaction Network for BDNF-TrkB signaling

Sources for BDNF-TrkB signaling